Related Experiment Video
Updated: May 18, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
A bumpy road to the diagnosis of a Kytococcus schroeteri shunt infection
Frieder Schaumburg1, Christian Schmalstieg2, Barbara Fiedler2
1Institute of Medical Microbiology, University Hospital Münster, Münster, Germany.
Abstract:
We report a ventriculoperitoneal shunt infection associated with Kytococcus schroeteri, a Gram-positive bacterium from the family Dermacoccaceae. While the biochemical identification systems do not reliably identify this potential pathogen, sequence-based identification is recommended to guide the antibiotic treatment of this intrinsically meticillin-resistant species, which is susceptible to vancomycin, gentamicin and/or rifampicin.
Insights
Kytococcus schroeteri, a rare Gram-positive bacterium, can cause ventriculoperitoneal shunt infections. Sequence-based identification is crucial for effective antibiotic treatment of this intrinsically meticillin-resistant pathogen.
Area of Science:
- Microbiology
- Infectious Diseases
- Neurosurgery
Background:
- Ventriculoperitoneal shunts are used to treat hydrocephalus.
- Shunt infections are a serious complication, often caused by common bacteria.
- The identification of rare pathogens can be challenging.
Observation:
- A case of ventriculoperitoneal shunt infection caused by Kytococcus schroeteri is reported.
- Kytococcus schroeteri is a Gram-positive bacterium belonging to the Dermacoccaceae family.
Findings:
- Standard biochemical identification systems may not reliably identify Kytococcus schroeteri.
- Sequence-based identification is recommended for accurate pathogen diagnosis.
- Kytococcus schroeteri is intrinsically meticillin-resistant.
- The species is susceptible to vancomycin, gentamicin, and/or rifampicin.
Implications:
- Accurate identification of Kytococcus schroeteri is essential for appropriate antibiotic selection.
- This finding highlights the importance of advanced diagnostic methods in managing shunt infections.
- Understanding the antimicrobial susceptibility of rare pathogens is critical for patient outcomes.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urine Studies II: Urine Culture and Sensitivity Test
Urinary Tract Infection I: Introduction
